ArticleToxicological research2024

Adverse events associated with SARS-CoV-2 neutralizing monoclonal antibodies using the FDA adverse event reporting system database.

Min Joung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.